CUSP-02

N/A

Report date: 2023/10/24 17:09:05

Base Information

Drug NameCUSP-02

Drug Alias NameCUSP-02

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAngiogenesis inhibitors

TargetsUpdating

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesOnCusp Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesOnCusp Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A